Adagrasib is an innovative KRASG12C-targeted inhibitor that has shown promising efficacy in the treatment of non-small cell lung cancer and colorectal cancer.

What Are the Purchase Channels for Adagrasib?

Overseas Purchase

Patients may choose to consult and purchase adagrasib at hospital pharmacies or legitimate drugstores in countries or regions where the medication has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make budgets and plans in advance before purchasing.

Purchase Through Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions typically provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Adagrasib

Genetic Testing Before Medication Use

KRASG12C mutation testing must be conducted before using adagrasib.

Testing can be performed using plasma or tumor samples. If no mutation is detected in the plasma sample, tumor tissue testing is required.

Assessment of Individual Medication Suitability

Patients need to assess whether they are suitable for using this medication.

Particularly for patients with heart problems, abnormal liver function, or those taking other medications, a comprehensive assessment must be conducted under the guidance of a doctor.

Management of Common Adverse Reactions

Common adverse reactions of adagrasib include gastrointestinal reactions and hepatotoxicity.

Clinical data shows that the incidence of nausea, diarrhea, and vomiting is relatively high, so corresponding supportive treatment medications should be prepared in advance.

Drug Interactions

Avoid concurrent use with strong CYP3A4 inducers.

Avoid concurrent use with strong CYP3A4 inhibitors until a steady-state concentration is achieved.

Avoid simultaneous use with sensitive CYP3A4 substrates.

Avoid using other products known to potentially prolong the QT interval.

Methods to Distinguish Authenticity of Adagrasib

Identification of Physical Characteristics

Legitimate adagrasib tablets have clear physical features: 200mg oval tablets, white to off-white in color, with "200" engraved on one side and a stylized "M" logo on the other side.

Verification of Packaging Information

Authentic products are packaged in high-density polyethylene white opaque square bottles, equipped with desiccants and child-resistant seals.

Verification of Manufacturer Information

Adagrasib was developed by Mirati Therapeutics and has now been acquired by Bristol Myers Squibb.

When purchasing, verify that the manufacturer information on the drug packaging is consistent with official materials.

Query of Approval Number

Querying the drug approval number through official channels is an effective method to verify authenticity.

Legitimate drugs all have a unique approval number, which can be verified on the websites of relevant regulatory authorities.

Verification of Drug Code

Legitimate adagrasib has specific national drug codes, and this information should be carefully checked during purchase.